Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Quest Diagnostics fits the bill. Thus, it seems as ...

Quest Diagnostics (NYSE:DGX), a leader in diagnostic testing and information services, released its fourth quarter results on ...

Quest Diagnostics reported fourth-quarter revenue of $2.62 billion, beating analyst estimates of $2.58 billion, according to Benzinga Pro. The company reported fourth-quarter adjusted earnings of ...